{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:21:59Z","timestamp":1760833319312,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.breast.2016.12.020","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T15:38:37Z","timestamp":1483630717000},"page":"73-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy \u2013 A retrospective pooled analysis of individual patients data of four German neoadjuvant trials"],"prefix":"10.1016","volume":"32","author":[{"given":"Mattea","family":"Reinisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Huober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunter","family":"von Minckwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens-Uwe","family":"Blohmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Denkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Hanusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Jackisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherko","family":"K\u00fcmmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Rhiem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Lederer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Untch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Nekljudova V","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibylle","family":"Loibl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2016.12.020_bib1","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1200\/JCO.2011.35.0165","article-title":"A\u00a0case-match study comparing unilateral with synchronous bilateral breast cancer outcomes","volume":"29","author":"Nichol","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2016.12.020_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10549-014-3045-0","article-title":"Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies","volume":"146","author":"Holm","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2016.12.020_bib3","first-page":"733","article-title":"Bilateral breast cancer","volume":"59","author":"Gogas","year":"1993","journal-title":"Am Surg"},{"key":"10.1016\/j.breast.2016.12.020_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.2015.62.3942","article-title":"Impact of age at primary breast cancer on contralateral breast cancer risk in BRCA1\/2 mutation carriers","volume":"34","author":"van den Broek","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2016.12.020_bib5","unstructured":"http:\/\/familiaerer-brust-und-eierstockkrebs.uk-koeln.de\/aerzte\/2016-checkliste-genetik.pdf n.d."},{"key":"10.1016\/j.breast.2016.12.020_bib6","unstructured":"http:\/\/www.ago-online.de\/fileadmin\/downloads\/leitlinien\/mamma\/Maerz2016\/de\/ n.d."},{"key":"10.1016\/j.breast.2016.12.020_bib7","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2016.12.020_bib8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s12282-014-0524-4","article-title":"Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG","volume":"22","author":"Kuroi","year":"2015","journal-title":"Breast Cancer"},{"key":"10.1016\/j.breast.2016.12.020_bib9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/jnci\/djn089","article-title":"Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study","volume":"100","author":"von Minckwitz","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2016.12.020_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/annonc\/mdi001","article-title":"In\u00a0vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study","volume":"16","author":"von Minckwitz","year":"2005","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.breast.2016.12.020_bib11","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1200\/JCO.2009.23.8303","article-title":"Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study","volume":"28","author":"von Minckwitz","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2016.12.020_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/annonc\/mdq350","article-title":"Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial","volume":"22","author":"von Minckwitz","year":"2011","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.breast.2016.12.020_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1470-2045(11)70397-7","article-title":"Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial","volume":"13","author":"Untch","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2016.12.020_bib14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1470-2045(14)70160-3","article-title":"Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial","volume":"15","author":"von Minckwitz","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2016.12.020_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-012-2233-z","article-title":"Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer","volume":"136","author":"Lips","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2016.12.020_bib16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3816\/CBC.2007.n.052","article-title":"Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival","volume":"7","author":"Beinart","year":"2007","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2016.12.020_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0960-9776(02)00278-3","article-title":"Synchronous, bilateral breast cancer: prognostic value and incidence","volume":"12","author":"Jobsen","year":"2003","journal-title":"Breast"},{"key":"10.1016\/j.breast.2016.12.020_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-015-3538-5","article-title":"Bilateral breast cancer, synchronous and metachronous; differences and outcome","volume":"153","author":"Jobsen","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2016.12.020_bib19","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.7314\/APJCP.2015.16.12.4921","article-title":"Properties of synchronous versus metachronous bilateral breast carcinoma with long time follow up","volume":"16","author":"Eliyatkin","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.breast.2016.12.020_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10549-010-1057-y","article-title":"Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics","volume":"126","author":"Kheirelseid","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2016.12.020_bib21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/cncr.20452","article-title":"Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution","volume":"101","author":"Intra","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2016.12.020_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.breast.2010.10.004","article-title":"Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort","volume":"20","author":"Beckmann","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.breast.2016.12.020_bib23","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.289.11.1421","article-title":"Trends in incidence rates of invasive lobular and ductal breast carcinoma","volume":"289","author":"Li","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2016.12.020_bib24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00432-011-1141-7","article-title":"Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer","volume":"138","author":"Shi","year":"2012","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.breast.2016.12.020_bib25","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.1995.13.7.1578","article-title":"Contralateral breast cancer: annual incidence and risk parameters","volume":"13","author":"Bro\u00ebt","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2016.12.020_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-014-2861-6","article-title":"Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma","volume":"144","author":"Loibl","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2016.12.020_bib27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1067\/msy.2000.108780","article-title":"Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts","volume":"128","author":"Hungness","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.breast.2016.12.020_bib28","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1245\/s10434-015-4746-2","article-title":"Breast-conserving surgery in bilateral breast cancer","volume":"22","author":"O'Brien","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2016.12.020_bib29","doi-asserted-by":"crossref","unstructured":"Heaton KM, Peoples GE, Singletary SE, Feig BW, Ross MI, Ames FC, et\u00a0al. Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer. Ann Surg Oncol n.d.;6:102\u20138.","DOI":"10.1007\/s10434-999-0102-8"},{"key":"10.1016\/j.breast.2016.12.020_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1470-2045(05)70174-1","article-title":"Genetic implications of bilateral breast cancer: a population based cohort study","volume":"6","author":"Hartman","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2016.12.020_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/bjs.1800710924","article-title":"Bilateral primary breast cancer: a prospective study of disease incidence","volume":"71","author":"Chaudary","year":"1984","journal-title":"Br J Surg"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977616302892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977616302892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:35:43Z","timestamp":1760776543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977616302892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"alternative-id":["S0960977616302892"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2016.12.020","relation":{},"ISSN":["0960-9776"],"issn-type":[{"type":"print","value":"0960-9776"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy \u2013 A retrospective pooled analysis of individual patients data of four German neoadjuvant trials","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2016.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}